Dublin, Ireland

Conor Henry

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Conor Henry: Innovator in Skin Disorder Treatments

Introduction: Conor Henry, based in Dublin, Ireland, is a prominent inventor focused on innovative solutions for inflammatory skin disorders. His work aims to significantly improve treatment methodologies that address challenging dermatological conditions.

Latest Patents: Conor Henry holds a patent titled "Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing." This groundbreaking invention explores the use of agents that inhibit IL-36 proteolytic processing to treat and reduce inflammation in affected individuals. By preventing the production of biologically active IL-36, this method effectively mitigates the pro-inflammatory effects associated with the protein. The patent also encompasses compositions and methods designed to alleviate inflammation, showcasing an exciting advancement in therapeutic options.

Career Highlights: Conor is affiliated with the College of the Holy including the Provost, Fellows, Foundation Scholars, and other members of the board. His innovative contributions within the institution reflect a commitment to advancing scientific research and application in the biomedical field.

Collaborations: Throughout his career, Conor has had the opportunity to work alongside esteemed colleagues such as Seamus J Martin and Graeme Sullivan. These collaborations enhance the potential for meaningful advancements in the treatment of skin disorders and underline the importance of teamwork in scientific innovation.

Conclusion: Conor Henry's dedication to developing effective treatments for inflammatory skin disorders has made a significant impact in the field of dermatology. His innovative approach, as evidenced by his patent on IL-36 inhibition, holds promise for improving patient outcomes and offers a glimpse into the future of dermatological therapies. As he continues his work at the College of the Holy, his contributions will undoubtedly inspire further advancements in medical research and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…